Larvol Delta - NCI201903536-Modified-Immune-Cells-AFM13NK-and-A-Monoclonal-Antibody-AFM13-in-Treating-Patients-With-Recurrent-or-Refractory-CD30-Positive-Hodgkin-or-NonHodgkin-Lymphomas

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

acimtamig (AFM13) - Affimed

http://clinicaltrials.gov/ct2/show/NCT04074746

Apr 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next